ArticleACS omega2026
Morphological Modulation and Performance Tuning of Perylene-Porphyrin-Based Covalent Organic Frameworks.
Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Large-scale production of covalent organic frameworks (COFs) has been hindered due to their poor reproducibility. Precisely controlling the growth of COFs can be achieved via alterations to synthesis parameters. A strategy for synthesizing reproducible perylene-porphyrin-based COFs over a range of temperatures is presented, with the aim to evaluate their morphology and functionality. Morphological modifications from nanospheres to nanofibers were observed at higher synthesis temperatures, which enhanced chemisorption in methylene blue removal experiments. Photoluminescence and transient absorption spectroscopy measurements showed efficient light absorption over the visible region and ultrafast excited-state deactivation, representative of a potential equilibrium with a charge-separated state, indicating the valuable photophysical behavior of our COFs.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.